Literature DB >> 25538045

Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function.

Marjolein Meinders1, Divine I Kulu2, Harmen J G van de Werken2, Mark Hoogenboezem3, Hans Janssen4, Rutger W W Brouwer5, Wilfred F J van Ijcken5, Erik-Jan Rijkers6, Jeroen A A Demmers6, Imme Krüger7, Timo K van den Berg1, Guntram Suske7, Laura Gutiérrez1, Sjaak Philipsen2.   

Abstract

Sp1 and Sp3 belong to the specificity proteins (Sp)/Krüppel-like transcription factor family. They are closely related, ubiquitously expressed, and recognize G-rich DNA motifs. They are thought to regulate generic processes such as cell-cycle and growth control, metabolic pathways, and apoptosis. Ablation of Sp1 or Sp3 in mice is lethal, and combined haploinsufficiency results in hematopoietic defects during the fetal stages. Here, we show that in adult mice, conditional pan-hematopoietic (Mx1-Cre) ablation of either Sp1 or Sp3 has minimal impact on hematopoiesis, whereas the simultaneous loss of Sp1 and Sp3 results in severe macrothrombocytopenia. This occurs in a cell-autonomous manner as shown by megakaryocyte-specific (Pf4-Cre) double-knockout mice. We employed flow cytometry, cell culture, and electron microscopy and show that although megakaryocyte numbers are normal in bone marrow and spleen, they display a less compact demarcation membrane system and a striking inability to form proplatelets. Through megakaryocyte transcriptomics and platelet proteomics, we identified several cytoskeleton-related proteins and downstream effector kinases, including Mylk, that were downregulated upon Sp1/Sp3 depletion, providing an explanation for the observed defects in megakaryopoiesis. Supporting this notion, selective Mylk inhibition by ML7 affected proplatelet formation and stabilization and resulted in defective ITAM receptor-mediated platelet aggregation.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25538045     DOI: 10.1182/blood-2014-08-593343

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Inefficient megakaryopoiesis in mouse hematopoietic stem-progenitor cells lacking T-bet.

Authors:  Aki Furusawa; Kavitha Sadashivaiah; Zeba N Singh; Curt I Civin; Arnob Banerjee
Journal:  Exp Hematol       Date:  2015-11-19       Impact factor: 3.084

2.  Identification of the transcription factor MAZ as a regulator of erythropoiesis.

Authors:  Darya Deen; Falk Butter; Deborah E Daniels; Ivan Ferrer-Vicens; Daniel C J Ferguson; Michelle L Holland; Vasiliki Samara; Jacqueline A Sloane-Stanley; Helena Ayyub; Matthias Mann; Jan Frayne; David Garrick; Douglas Vernimmen
Journal:  Blood Adv       Date:  2021-08-10

3.  Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer.

Authors:  Andrea Sacchetti; Miriam Teeuwssen; Mathijs Verhagen; Rosalie Joosten; Tong Xu; Roberto Stabile; Berdine van der Steen; Martin M Watson; Alem Gusinac; Won Kyu Kim; Inge Ubink; Harmen Jg Van de Werken; Arianna Fumagalli; Madelon Paauwe; Jacco Van Rheenen; Owen J Sansom; Onno Kranenburg; Riccardo Fodde
Journal:  Elife       Date:  2021-05-26       Impact factor: 8.140

4.  Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment.

Authors:  Marjolein Meinders; Mark Hoogenboezem; Maaike R Scheenstra; Iris M De Cuyper; Petros Papadopoulos; Tamás Németh; Attila Mócsai; Timo K van den Berg; Taco W Kuijpers; Laura Gutiérrez
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

5.  Integrated genome-wide analysis of expression quantitative trait loci aids interpretation of genomic association studies.

Authors:  Roby Joehanes; Xiaoling Zhang; Tianxiao Huan; Chen Yao; Sai-Xia Ying; Quang Tri Nguyen; Cumhur Yusuf Demirkale; Michael L Feolo; Nataliya R Sharopova; Anne Sturcke; Alejandro A Schäffer; Nancy Heard-Costa; Han Chen; Po-Ching Liu; Richard Wang; Kimberly A Woodhouse; Kahraman Tanriverdi; Jane E Freedman; Nalini Raghavachari; Josée Dupuis; Andrew D Johnson; Christopher J O'Donnell; Daniel Levy; Peter J Munson
Journal:  Genome Biol       Date:  2017-01-25       Impact factor: 13.583

6.  miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling.

Authors:  Yan Feng; Yan Li; Ying Zhang; Bo-Hao Zhang; Hui Zhao; Xin Zhao; Fu-Dong Shi; Wei-Na Jin; Xiao-An Zhang
Journal:  J Neuroinflammation       Date:  2021-06-12       Impact factor: 8.322

7.  Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling.

Authors:  Seth A Domfeh; Patrick W Narkwa; Osbourne Quaye; Kwadwo A Kusi; Gordon A Awandare; Charles Ansah; Alimatu Salam; Mohamed Mutocheluh
Journal:  BMC Complement Med Ther       Date:  2021-06-02

8.  Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg(2+) homeostasis and cytoskeletal architecture.

Authors:  Simon Stritt; Paquita Nurden; Remi Favier; Marie Favier; Silvia Ferioli; Sanjeev K Gotru; Judith M M van Eeuwijk; Harald Schulze; Alan T Nurden; Michele P Lambert; Ernest Turro; Stephanie Burger-Stritt; Masayuki Matsushita; Lorenz Mittermeier; Paola Ballerini; Susanna Zierler; Michael A Laffan; Vladimir Chubanov; Thomas Gudermann; Bernhard Nieswandt; Attila Braun
Journal:  Nat Commun       Date:  2016-03-29       Impact factor: 14.919

9.  Trefoil factor family 2 expression inhibits gastric cancer cell growth and invasion in vitro via interactions with the transcription factor Sp3.

Authors:  Yiling Cai; Mengting Yi; Dajun Chen; Jingjing Liu; Bayasi Guleng; Jianlin Ren; Huaxiu Shi
Journal:  Int J Mol Med       Date:  2016-09-19       Impact factor: 4.101

10.  Monitoring storage induced changes in the platelet proteome employing label free quantitative mass spectrometry.

Authors:  Maaike Rijkers; Bart L van den Eshof; Pieter F van der Meer; Floris P J van Alphen; Dirk de Korte; Frank W G Leebeek; Alexander B Meijer; Jan Voorberg; A J Gerard Jansen
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.